Population-based case-control study of soyfood intake and breast cancer risk in Shanghai

被引:177
作者
Dai, Q
Shu, XO
Jin, F
Potter, JD
Kushi, LH
Teas, J
Gao, YT
Zheng, W
机构
[1] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
[3] Shanghai Canc Inst, Dept Epidemiol, Shanghai 200032, Peoples R China
[4] Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98109 USA
[5] Columbia Univ, New York, NY 10027 USA
[6] Univ S Carolina, Sch Publ Hlth, Columbia, SC 29203 USA
关键词
breast cancer; body mass index; ER and PR; soyfood;
D O I
10.1054/bjoc.2001.1873
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We evaluated the association of soyfood intake and breast cancer risk in a population-based case-control study among Chinese women in Shanghai. Included in the study were 1459 cases and 1556 age-matched controls, with respective response rates of 91.1% and 90.3%. Usual soyfood intake was assessed using a food frequency questionnaire (FFQ). Separate analyses were performed for all subjects and for the subset who reported no recent change in soyfood intake. The intake levels of soyfoods among women in Shanghai are high, with 96.6% women reporting soyfood consumption at least once a week. A statistically non-significant reduced risk (odds ratio (OR) = 0.78 95% CI = 0.52-1.16) of breast cancer was observed among those who reported eating soyfood at least once a week. Compared to those in the lowest decile intake group, women in the highest decile intake group had a 30% reduced risk of breast cancer (OR = 0.66, 95% CI = 0.46-0.95), but no monotonic dose-response relation was observed (P for trend, 0.28). Stratified analyses showed that the inverse association was restricted primarily among women who had a high body mass index (BMI), with an adjusted OR of 0.30 (95% Cl = 0.10-0.94) observed for the highest intake group. The reduction in risk was stronger for breast cancer positive for both oestrogen receptor (ER) and progesterone, receptor (PR) (OR = 0.44, 95% Cl = 0.25-0.78) than those with other ER/PR status. More pronounced inverse associations were observed in analyses among those who reported no recent change in soyfood intake than those conducted in all subjects. A dose-response relation between soyfood intake and breast cancer risk was observed in this subset of women (P for trend, 0.02), with an OR of 0.46 (95% CI = 0.28-0.75) for those in the highest decile intake group. No clear monotonic dose-response relation was found between soyfood intake and breast cancer risk among regular soy eaters, but nevertheless the results suggest that regular soyfood consumption may reduce the risk of breast cancer, particularly for those positive for ER and PR; the effect may be modified by body mass index. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 43 条
[1]   Phyto-oestrogens and Western diseases [J].
Adlercreutz, H ;
Mazur, W .
ANNALS OF MEDICINE, 1997, 29 (02) :95-120
[2]  
[Anonymous], 1991, J EPIDEMIOL COMMUN H, DOI DOI 10.1136/JECH.45.2.173
[3]  
Breslow NE, 1980, STAT METHODS CANC RE, P122
[4]   INSULIN RESISTANCE AND BREAST-CANCER RISK [J].
BRUNING, PF ;
BONFRER, JMG ;
VANNOORD, PAH ;
HART, AAM ;
DEJONGBAKKER, M ;
NOOIJEN, WJ .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (04) :511-516
[5]   Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai [J].
Chen, Z ;
Zheng, W ;
Custer, LJ ;
Dai, Q ;
Shu, XO ;
Jin, F ;
Franke, AA .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1999, 33 (01) :82-87
[6]  
*CHIN AC MED SCI, 1991, FOOD COMP TABL
[7]  
CONSTANTINOU AL, 2000, AACR M
[8]   Modest hormonal effects of soy isoflavones in postmenopausal women [J].
Duncan, AM ;
Underhill, KEW ;
Xu, X ;
Lavalleur, J ;
Phipps, WR ;
Kurzer, MS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3479-3484
[9]  
Greenstein J., 1996, American Journal of Epidemiology, V143, pS36
[10]   Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [J].
Hankinson, SE ;
Willett, WC ;
Colditz, GA ;
Hunter, DJ ;
Michaud, DS ;
Deroo, B ;
Rosner, B ;
Speizer, FE ;
Pollak, M .
LANCET, 1998, 351 (9113) :1393-1396